Literature DB >> 14654065

Cytochrome P450: major player in reperfusion injury.

Roberta A Gottlieb1.   

Abstract

While attention has historically focused on mitochondria as the primary source of ROS in myocardial ischemia/reperfusion injury, recent evidence has implicated cytochrome P450 monooxygenases (CYPs) as a significant factor. CYPs represent a large family of enzymes that catalyze the oxidation of endogenous and exogenous compounds. They catalyze arachidonic acid oxidation to a variety of biologically active eicosanoids that regulate ion channels and protein kinases, with effects on vasomotor tone and cardiac inotropy. They also represent a significant source of reactive oxygen species that may target cellular homeostatic mechanisms and mitochondria. In this review, we will consider the contribution of cytochrome P450 enzymes to reperfusion injury and will speculate on whether the mechanism of injury is due to CYP-mediated ROS production or arachidonic acid metabolites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654065     DOI: 10.1016/j.abb.2003.07.004

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

1.  Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.

Authors:  Tracy C Delozier; Grace E Kissling; Sherry J Coulter; Diana Dai; Julie F Foley; J Alyce Bradbury; Elizabeth Murphy; Charles Steenbergen; Darryl C Zeldin; Joyce A Goldstein
Journal:  Drug Metab Dispos       Date:  2007-01-12       Impact factor: 3.922

Review 2.  Regulation of drug-metabolizing enzymes by local and systemic liver injuries.

Authors:  Yan Guo; Bingfang Hu; Yang Xie; Timothy R Billiar; Jason L Sperry; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-01-28       Impact factor: 4.481

3.  Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.

Authors:  Garrett J Gross; Anna Hsu; John R Falck; Kasem Nithipatikom
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

4.  Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening.

Authors:  Charles E Leonard; Meijia Zhou; Colleen M Brensinger; Warren B Bilker; Samantha E Soprano; Thanh Phuong Pham Nguyen; Young Hee Nam; Jordana B Cohen; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2019-07-04       Impact factor: 6.875

5.  Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.

Authors:  Charles E Leonard; Colleen M Brensinger; Warren B Bilker; Stephen E Kimmel; Xu Han; Young Hee Nam; Joshua J Gagne; Margaret J Mangaali; Sean Hennessy
Journal:  Int J Cardiol       Date:  2016-11-12       Impact factor: 4.164

Review 6.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

7.  Mapping hole hopping escape routes in proteins.

Authors:  Ruijie D Teo; Ruobing Wang; Elizabeth R Smithwick; Agostino Migliore; Michael J Therien; David N Beratan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-24       Impact factor: 11.205

Review 8.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 9.  Redox regulation of the immune response.

Authors:  Johanna M Gostner; Kathrin Becker; Dietmar Fuchs; Robert Sucher
Journal:  Redox Rep       Date:  2013-04-19       Impact factor: 4.412

Review 10.  Bcl-2 family proteins as regulators of oxidative stress.

Authors:  Nathan Susnow; Liyun Zeng; Daciana Margineantu; David M Hockenbery
Journal:  Semin Cancer Biol       Date:  2008-12-24       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.